{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-032169","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.585716+00:00","generated_at":"2026-05-31T09:16:17.630485+00:00","sec_items":["1.01","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"TNF Pharmaceuticals amends Series G Preferred Stock dividend calculation method","bullets":["Amendment changes how in-kind dividends (additional Preferred Stock shares) are determined.","Certificate of Amendment filed with Delaware Secretary of State on August 8, 2024.","Amendment approved by Required Holders (majority of outstanding Preferred Stock).","Other terms of Series G Preferred Stock and related documents remain unchanged.","Event modifies rights of security holders under Item 3.03."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-032169","json":"https://secwatch.observer/filing/0001493152-24-032169.json","markdown":"https://secwatch.observer/filing/0001493152-24-032169.md","text":"https://secwatch.observer/filing/0001493152-24-032169.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224032169/0001493152-24-032169-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224032169/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:16:17.630485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}